King Review: What's in and what's out
A wrap-up of the review that's been three years in the making
4th May 2018
It’s taken nearly three years from whoa to go and has been beleaguered by delays, but the pharmacy review is finally a wrap.
Here is a review of the key final report recommendations and how the government has responded:
What’s in
- Pharmacies to pay less up-front for high-cost medicines: The panel recommended a cap of $700-$1000. While the government has put a cap on hold for now, it’s bringing in changes to the way payments are administered to make these drugs more affordable for pharmacies. The new arrangements will be trialled from 1 July 2019.